GLP-1 agonists reduced the risk of suicidal thoughts in adolescents
A cohort study by Israeli scientists found that adolescents treated with glucagon-like peptide-1 (GLP-1) receptor agonists had a 33 percent lower risk of suicidal thoughts or attempts compared to controls…